REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/27/2026
Back to search
Official data from USPTO
SEBELA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEBELA PHARMACEUTICALS
ST13
US500000086980925Class
5
Filing
86980925
Registration
5233626
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
06/27/2026
Trademark type
Word
Nice classes
5
Filing date
09/30/2015
Registration date
06/27/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/10/2024
Last transaction
06/27/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2013-09-00
First use in commerce
2013-09-00
Drawing code
4
Owner type
11
Owner location
DUBLIN, IE
Examiner
BIDDULPH, HEATHER ANN
Law office
N70
Current location
TMO LAW OFFICE 125
Holders and representatives
Holders
SEBELA IRELAND LIMITED
SEBELA INTERNATIONAL BERMUDA LIMITED
Sebela International Limited
Representatives
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicated preparationsfor use in dermatologygastroenterologyrheumatologyfor use in the treatment of psychiatric disorders
Publications
History of USPTO decisions and trademark events.
46 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/10/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
07/17/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/27/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/24/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/04/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/24/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/19/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/19/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/19/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2017
GNRT
NON-FINAL ACTION E-MAILED
03/09/2017
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/09/2017
DOCK
ASSIGNED TO EXAMINER
11/22/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/11/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/10/2016
DPCC
DIVISIONAL PROCESSING COMPLETE
11/10/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/10/2016
IUAF
USE AMENDMENT FILED
10/21/2016
DRRR
DIVISIONAL REQUEST RECEIVED
10/21/2016
EX1G
SOU EXTENSION 1 GRANTED
10/21/2016
EXT1
SOU EXTENSION 1 FILED
10/21/2016
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
10/21/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/21/2016
EISU
TEAS STATEMENT OF USE RECEIVED
10/21/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/20/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/20/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/07/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2016
PUBO
PUBLISHED FOR OPPOSITION
04/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/08/2016
ALIE
ASSIGNED TO LIE
03/04/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
01/29/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/29/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
01/29/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/29/2016
DOCK
ASSIGNED TO EXAMINER
01/20/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2015
NWAP
NEW APPLICATION ENTERED
10/03/2015
Continuous trademark protection
Get notified about every new filing that threatens SEBELA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.